81311 Nras gene variants exon 2&3
Also known as: NRAS mutation test, RAS pathway mutation analysis
Neuroblastoma RAS viral oncogene homolog (NRAS) gene variant analysis for mutations in exons 2 and 3 in hematologic malignancies.
In Plain Language
Blood cancer mutation test; Leukemia genetic marker
Clinical Context
Detects NRAS mutations in acute myeloid leukemia and other hematologic malignancies to guide prognosis and treatment selection.
RVU Information
CPT 81311 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81311?
CPT 81311 (Nras gene variants exon 2&3) is a Pathology & Lab code. Neuroblastoma RAS viral oncogene homolog (NRAS) gene variant analysis for mutations in exons 2 and 3 in hematologic malignancies.
Who uses CPT code 81311?
CPT 81311 is used by Pathology, Hematology, Oncology. Detects NRAS mutations in acute myeloid leukemia and other hematologic malignancies to guide prognosis and treatment selection.
When is CPT 81311 used?
Detects NRAS mutations in acute myeloid leukemia and other hematologic malignancies to guide prognosis and treatment selection.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.